ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 763

Comparison of Clinical Characteristics and Outcome between Isolated and Classic Lupus Nephritis

Kubra Bugdayli1, Cynthia S. Crowson2, Ladan Zand3, Mariam P. Alexander4, Lynn D. Cornell4 and Vaidehi R. Chowdhary5, 1Department of Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Nephrology and Hypertension, Mayo Clinic, Rochester, MN, 4Anatomic Pathology, Mayo Clinic College of Medicine and Science, Rochester, MN, 5Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: Lupus, Lupus nephritis, outcomes, renal disease and systemic lupus erythematosus (SLE)

Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Comparison of clinical characteristics and outcome between isolated and classic lupus nephritis

Background/Purpose: Lupus nephritis (LN) is a serious manifestation of systemic lupus erythematosus (SLE). Rarely, patients may present with LN alone and have no extra-renal clinical manifestations of lupus (isolated lupus nephritis, ILN). We aimed to describe the clinical characteristics of patients presenting with isolated LN and to study their treatment outcome and long term survival and its predictors compared to classic LN.

Methods: Subjects were identified by searching a pathologic renal biopsy database. Clinical records were reviewed for exclusion of infectious and secondary causes. Cases with isolated LN were defined per 2012 SLICC criteria; classic SLE patients had lupus nephritis along with extra-renal manifestations of lupus. Complete response (CR) was defined as proteinuria <0.5 g/24 h and serum creatinine (sCr) within 125% of the baseline value after the start of induction therapy. Partial response (PR) was defined as reduction of proteinuria of >50% (and at least <3.0 g/24 hours) plus sCr within 125% of the baseline value after the start of the induction therapy.

Results: 30 patients with isolated LN and 134 patients with classic LN were identified. The median age at the time of biopsy was 41 and 39 years, for the ILN and LN group, respectively. Majority were Caucasian; female to male ratio was 3:1 in ILN and 2:1 in the LN group. The median duration from renal symptoms to biopsy was 5.2 months for ILN and 1.2 for the LN group (p=0.013). Mean sCr was 1.7 mg/dl and 1.3 mg/dl and 24 hour proteinuria 8.5 and 4.9 g, respectively. A greater percentage of patients with ILN had hypertension at onset (83% versus 35% in LN, p<0.001) and interstitial fibrosis in biopsies (97% ILN versus 69% LN, p=0.018). The outcomes and survival among 18 ILN and 72 LN patients of class 3, 4 or mixed are noted in Table.

 

ILN

LN

Complete response (95% CI)

12 mo

5 year

10 year

23 (10, 54)

48 (29, 80)

62 (39, 99)

42 (32, 55)

67 (57, 80)

70 (59, 83)

Complete and/or partial (95% CI) response

12 mo

5 year

10 year

51 (32, 80)

69 (50, 95)

85 (64, 100)

58 (48, 71)

82 (73, 92)

88 (79, 98)

ESRD/Renal transplant (95% CI)

12 mo

5 year

10 year

6 (0, 40)

12 (3, 45)

30 (13, 71)

4 (1, 13)

17 (10, 30)

27 (17, 44)

Survival (95% CI)

12 mo

5 year

10 year

94 (84, 100)

88 (74, 100)

64 (40,100)

 

99 (96, 100)

94 (87, 100)

87 (77, 100)

Conclusion: The response rates and 10 year survival tended to be higher in the LN group compared to ILN. Possible late recognition and/or under treatment of this subset may be underlying the differences.


Disclosure: K. Bugdayli, None; C. S. Crowson, None; L. Zand, None; M. P. Alexander, None; L. D. Cornell, None; V. R. Chowdhary, None.

To cite this abstract in AMA style:

Bugdayli K, Crowson CS, Zand L, Alexander MP, Cornell LD, Chowdhary VR. Comparison of Clinical Characteristics and Outcome between Isolated and Classic Lupus Nephritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparison-of-clinical-characteristics-and-outcome-between-isolated-and-classic-lupus-nephritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-clinical-characteristics-and-outcome-between-isolated-and-classic-lupus-nephritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology